Cleared Traditional

LIPIFLOW THERMAL PULSATION SYSTEM (K112704) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
94d
Days
Class 2
Risk

K112704 is an FDA 510(k) clearance for the LIPIFLOW THERMAL PULSATION SYSTEM. Classified as Eyelid Thermal Pulsation System (product code ORZ), Class II - Special Controls.

Submitted by Tearscience, Inc. (Morrisville, US). The FDA issued a Cleared decision on December 19, 2011 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5200 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Tearscience, Inc. devices

Submission Details

510(k) Number K112704 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 2011
Decision Date December 19, 2011
Days to Decision 94 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 110d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ORZ Eyelid Thermal Pulsation System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.5200
Definition Therapeutic Application Of Heat And Massage To The Eyelids.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - ORZ Eyelid Thermal Pulsation System

All 11
Devices cleared under the same product code (ORZ) and FDA review panel - the closest regulatory comparables to K112704.
TearCare MGX System
K252409 · Sight Sciences, Inc. · Apr 2026
TearCare MGX System
K242786 · Sight Sciences, Inc. · Apr 2025
Tixel i (TXLI0001)
K240512 · Novoxel , Ltd. · Nov 2024
TearCare MGX System
K231084 · Sight Sciences, Inc. · Dec 2023
TearCare System
K213045 · Sight Sciences, Inc. · Dec 2021
Systane iLux2
K200400 · Tear Film Innovations, Inc. · May 2020